ArticleMolecular neurobiology2026
Causal Links Between the Plasma Lipidome and Cognitive Performance: Targets, Pathways, and Lifestyle Influences.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The plasma lipidome has been implicated in brain health, yet whether specific lipid species exert causal effects on cognitive performance (CP) remains uncertain. We integrated whole-blood expression quantitative trait loci (eQTL) with CP genome-wide association studies using summary data-based Mendelian randomization (SMR) with heterogeneity in dependent instruments (HEIDI), followed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment. Two-sample Mendelian randomization (MR) estimated effects of 179 plasma lipid species on CP using inverse-variance weighted primary analysis. Two-step MR quantified mediation via 43 modifiable lifestyle and biochemical factors. Mendelian randomization phenome-wide association study (MR-PheWAS) assessed systemic consequences and potential pleiotropy. Using SMR with blood eQTLs and HEIDI test, we identified 1066 genes associated with CP enriched for lipid metabolism and membrane functions implicating phosphoinositide signaling. Two-sample MR analyses demonstrated heterogeneous causal effects of phosphatidylcholine-ether (PC-O) species on CP, with PC (O-16:0_20:3) positively associated with CP, whereas PC (O-18:1_18:2) (P = 0.025, OR = 0.984 (95% CI 0.969-0.998)) and PC (O-18:2_16:0) (P = 0.027, OR = 0.984 (95% CI 0.970-0.998)) showed adverse effects. Sphingomyelin (SM) (d36:1) exhibited a robust positive association with CP (P < 0.001, OR = 1.026 (95% CI 1.014-1.039)), remaining significant after sensitivity analyses. Fourteen modifiable factors associated with CP. HDL-C increased SM (d36:1) and PC (O-16:0_20:3) favoring CP, whereas poultry intake increased PC (O-18:1_18:2) impairing CP. SMR and MR support causal links between plasma lipids and CP. SM (d36:1) and select ether PCs emerge as candidate biomarkers or pathway mediators. These findings suggest that lipid-centered metabolic modulation may represent a potential strategy for preserving cognitive health, with lifestyle-related influences providing further support for integrated preventive approaches.
Indexed as
Identifiers
42322473What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.